Central artery pulse pressure, not central arterial stiffness impact on all-cause mortality in patients with viral pneumonia infection.

Central artery pulse pressure, not central arterial stiffness impact on all-cause mortality in patients with viral pneumonia infection.

Publication date: Oct 21, 2024

COVID-19 viral pneumonia can result in increased arterial stiffness, along with cardiac and systemic inflammatory responses. This study aimed to investigate the association between arterial stiffness, inflammation severity, and all-cause mortality in patients with COVID-19. In this study, anthropometric data, pneumonia infection severity, and blood tests were analyzed. Arterial stiffness was assessed using the non-invasive assessment indices, including arterial velocity pulse index (AVI) and central arterial pulse pressure (CAPP). Infection volumes and percentages for the whole lungs, most lobes, and most segments were extracted from CT images using artificial intelligence-based quantitative analysis software. The relationship between arterial stiffness, central hemodynamics, and all-cause mortality was investigated. In multivariable Cox regression analysis, high CAPP was significantly associated with all-cause mortality (hazard ratio: 0. 263, 95% CI, 0. 073-0. 945, pā€‰=ā€‰0. 041). Whole lung infection percentages were independently associated with high CAPP, with an area under the curve (AUC) of 0. 662 and a specificity of 89. 09%. High CAPP, but not high AVI, demonstrated independent prognostic value for all-cause mortality in patients due to COVID-19 pneumonia infection. Evaluating this parameter could help in risk assessment and improve diagnostic and therapeutic strategies in viral pneumonia infections.

Open Access PDF

Concepts Keywords
Covid Adult
Hemodynamics Aged
Intelligence Arterial stiffness
Pneumonia Artificial intelligence
Viral Blood Pressure
Blood pressure
COVID-19
Female
Humans
Lung
Male
Middle Aged
Pneumonia, Viral
Prognosis
SARS-CoV-2
Vascular Stiffness
Viral pneumonia

Semantics

Type Source Name
disease MESH arterial stiffness
disease MESH viral pneumonia
disease MESH infection
disease MESH COVID-19
disease MESH inflammation
disease MESH pneumonia
disease IDO blood
disease MESH Long Covid
pathway REACTOME Reproduction
disease MESH Infectious Diseases
disease MESH emergency
disease MESH viral infection
disease MESH hypoxia
drug DRUGBANK Coenzyme M
disease MESH coronavirus infection
disease MESH hyperplasia
drug DRUGBANK Oxygen
disease MESH fibrosis
disease MESH complications
drug DRUGBANK Medical air
disease MESH crazy paving pattern
drug DRUGBANK Methyprylon
disease MESH pleural effusion
drug DRUGBANK Indoleacetic acid
disease IDO facility
disease MESH sore throat
disease MESH dyspnea
disease MESH tachypnea

Original Article

(Visited 2 times, 1 visits today)